The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome

American Journal of Emergency Medicine

Volumn 26, Issue 6, 2008, Pages 711-715

  Wang, Houli ^a   Ma, Sui ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; NONSTEROID ANTIINFLAMMATORY AGENT;

CELL ACTIVATION; CORONARY BLOOD VESSEL; ENDOTHELIUM INJURY; INFLAMMATION; INFLAMMATORY CELL; MULTIPLE ORGAN FAILURE; PARENCHYMA; PATHOPHYSIOLOGY; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; UPREGULATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYTOKINES; HUMANS; MULTIPLE ORGAN FAILURE; STEROIDS;

EID: 46149105672     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2007.10.031     Document Type: Review

References (40)

1. Deitch E.A. Multiple organ failure, pathophysiology and potential future therapy. Ann Surg 216 (1992) 117-134
2. Marshall J.C. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 29 (2001) S99-S106
3. Allardyce D.B. Incidence of necrotizing pancreatitis and factors related to mortality. Am J Surg 154 (1987) 295-299
4. Faist E., Baue A.E., Dittmer H., et al. Multiple organ failure in polytrauma patients. J Trauma 23 (1983) 775-787
5. Marshall W.G., and Dimick A.R. Natural history of major burns with multiple subsystem failure. J Trauma 23 (1983) 102-105
6. Henao F.R., Daes J.E., and Denis R.J. Risk factors for multiorgan failure: a case-control study. J Trauma 31 (1991) 74-80
7. Pepe P.E., Potkin R.T., Reus D.H., et al. Clinical predictors of the adult respiratory distress syndrome. Am J Surg 144 (1982) 124-130
8. Volman T.J., Hendriks T., and Goris R.J. Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfunction syndrome. Shock 23 4 (2005) 291-297
9. Ader R., Cohen N., and Felten D. Psychoneuroimmunology. 2nd ed. (1991), Academic Press, New York
10. Seely A.J., and Christou N.V. Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Crit Care Med 28 7 (2000) 2193-2200
11. Panes J., Perry M.A., Anderson D.C., et al. Regional differences in constitutive and induced ICAM-1 expression in vivo. Am J Physiol 269 (1995) H1955-H1964
12. Henninger D.D., Panes J., Eppihimer M., et al. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol 158 (1997) 1825-1832
13. Bratt J., and Palmblad J. Cytokine-induced neutrophil-mediated injury of human endothelial cells. J Immunol. 159 2 (1997) 912-918
14. Thornhill M.H., Wellicome S.M., Mahiouz D.L., Lanchbury J.S., Kyan-Aung U., and Haskard D.O. Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and-independent binding mechanisms. J Immunol 146 2 (1991) 592-598
15. Wang J., and Qiao W.H. Study on vascular endothelial injuries and inflammation related cytokines in patients with multiple organ dysfunction syndrome. Zhongguo Weizhongbing Jijiu Yixue 18 2 (2006) 82-84
16. Olanders K., Sun Z., Borjesson A., et al. The effect of intestinal ischemia and reperfusion injury on ICAM-1 expression, endothelial barrier function, neutrophil tissue influx, and protease inhibitor levels in rats. Shock 18 1 (2002) 86-92
17. Haimovitz-Friedman A., Cordon-Cardo C., Bayoumy S., et al. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 186 (1997) 1831-1841
18. Stevenson B.R. Understanding tight junction clinical physiology at the molecular level. J Clin Invest 104 (1999) 3-4
19. Tsukita S., and Furuse M. The structure and function of claudins, cell adhesion molecules at tight junctions. Ann N Y Acad Sci 915 (2000) 129-135
20. Hotchkiss R.S., Swanson P.E., Freeman B.D., et al. Apoptotic cell death in patients with sepsis, shock and multiple organ dysfunction. Crit Care Med 27 (1999) 1230-1251
21. Coopersmith C.M., Stromberg P.E., Dunne W.M., et al. Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 287 (2002) 1716-1721
22. Deitch E.A., Xu D., and Kaise V.L. Role of the gut in the development of injury-and shock induced SIRS and MODS: the gut-lymph hypothesis, a review. Front Biosci 1 11 (2006) 520-528
23. Doig C.J., Suckerland L.R., Sandham J.D., Fick G.H., Verhoef M., and Meddings J.B. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med 158 (1998) 444-451
24. Fink M.P., and Delude R.L. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin 21 2 (2005) 177-196
25. Mukhopadhyay S., Hoidal J.R., and Mukherjee T.K. Role of TNFα in pulmonary pathophysiology. Respir Res 7 (2006) 125
26. Ware L.B., and Matthay M.A. The acute respiratory distress syndrome. N Engl J Med 342 (2000) 1334-1349
27. Costa E.L., Schettino I.A., and Schettino G.P. The lung in sepsis: guilty or innocent?. Endocr Metab Immune Disord Drug Targets 6 2 (2006) 213-216
28. Lee W.L., and Downey G.P. Neutrophil activation and acute lung injury. Curr Opin Crit Care 7 (2001) 1-7
29. Wiener-Kronish J.P., Albertine K.H., and Matthay M.A. Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J Clin Invest 88 (1991) 864-875
30. Pugin J., Verghese G., Widmer M.C., and Matthay M.A. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 27 (1999) 304-312
31. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342 (2000) 1301-1308
32. Tremblay L., Valenza F., Ribeiro S.P., et al. Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 99 (1997) 944-952
33. Ranieri V.M., Giunta F., Suter P.M., and Slutsky A.S. Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. JAMA 284 (2000) 43-44
34. Montgomery A.B., Stager M.A., Carrico C.J., and Hudson L.D. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 132 3 (1985) 485-489
35. Shimizu Y., Margenthaler J.A., Landeros K., Otomo N., Doherty G., and Flye M.W. The resistance of P. acnes-primed interferon gamma-deficient mice to low-dose lipopolysaccharide-induced acute liver injury. Hepatology 35 (2002) 805-814
36. Tsuji H., Mukaida N., Harada A., et al. Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacterium acnes-primed IFN-gamma-deficient mice by a concomitant reduction of TNF-α, IL-12, and IL-18 production. J Immunol 162 (1999) 1049-1055
37. Ghori K., Harmon D., Walsh F., and Shorten G. Effect of midazolam on in vitro cerebral endothelial ICAM-1 expression induced by astrocyte-conditioned medium. Eur J Anaesthesiol 23 9 (2006) 788-792
38. Fein A.M., Bernard G.R., Criner G.J., et al. Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127): results of a randomized, double-blind, placebo-controlled trial. JAMA 277 (1997) 482-487
39. Fisher Jr. C.J., Dhainaut J.F., Opal S.M., et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial. JAMA 271 (1994) 1836-1843
40. Zeni F., Freeman B., and Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 25 (1997) 1095-1100